Table 2.

Relationship between decreased ciprofloxacin susceptibility (<CIP, MIC 0.06–0.25 mg/L), full ciprofloxacin resistance (>CIP, MIC > 0.5 mg/L) and the most common genotypic quinolone resistance determinants in non-typhoidal Salmonella enterica.

Number of isolates	Phenotype				Genotype
	<CIP		>CIP
	S	R	S	R
116	6	110	114	2	gyrA[87:D-Y]
51	1	50	42	9	gyrA[83:S-Y];parC[57:T-S]
51	4	47	51	0	gyrA[87:D-N]
47	0	47	43	4	gyrA[83:S-Y]
44	0	44	39	5	parC[57:T-S];qnrS1
41	0	41	0	41	gyrA[83:S-F;87:D-Y];parC[57:T-S;80:S-I]
37	1	36	28	9	qnrS1
34	2	32	34	0	gyrA[87:D-Y];parC[57:T-S]
32	0	32	31	1	parC[57:T-S];qnrB19
29	1	28	28	1	gyrA[83:S-F];parC[57:T-S]
25	0	25	1	24	gyrA[83:S-F;87:D-N];parC[57:T-S;80:S-I]
23	0	23	20	3	gyrA[83:S-F]
19	2	17	19	0	gyrA[87:D-G]
17	2	15	17	0	gyrA[87:D-G];parC[57:T-S]
12	6	6	12	0	parC[57:T-S];qnrD
12	0	12	9	3	qnrB19
11	0	11	0	11	gyrA[83:S-F;87:D-G];parC[57:T-S;80:S-I]
11	0	11	11	0	gyrA[87:D-N];parC[57:T-S]
8	0	8	8	0	qnrA1
7	1	6	3	4	aac(6′)-Ib-cr
4	0	4	0	4	gyrA[83:S-Y];parC[57:T-S];qnrS1
4	0	4	0	4	gyrA[87:D-Y];qnrS1
4	0	4	4	0	parC[57:T-S];qnrB9
4	0	4	4	0	parC[57:T-S];qnrS2
4	0	4	2	2	qnrB6
3	0	3	0	3	gyrA[83:S-F;87:D-G];parC[57:T-S;80:S-R]
3	0	3	1	2	gyrA[83:S-Y];parC[57:T-S];qnrD
3	0	3	0	3	gyrA[83:S-Y];qnrS1
2	0	2	2	0	parC[57:T-S];qnrA1
2	0	2	2	0	parC[57:T-S];qnrB1

Values shown are the number of isolates. S, susceptible; R, Resistant.